Related Experiment Video
Updated: Jul 14, 2026

11:17
Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
Published on: February 27, 2026
Lung cancer: new surgical approaches
J Timothy Sherwood1, Malcolm V Brock
1Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. jsherwo1@jhmi.edu
Summary
Lung cancer treatment has evolved from open surgery to minimally invasive techniques and advanced diagnostics. Complete surgical resection remains crucial within comprehensive, multimodality lung cancer therapy.
Area of Science:
- Thoracic surgery
- Oncology
- Medical imaging
Background:
- The past two decades have seen a significant shift towards minimally invasive surgical procedures across specialties.
- Lung cancer surgery has increasingly adopted video-assisted thoracic surgical lobectomies.
- Innovations in imaging and adjuvant therapies have profoundly impacted surgical outcomes.
Purpose of the Study:
- To review the evolution of lung cancer treatment over the last 20 years.
- To highlight the integration of surgical techniques with advancements in imaging, chemotherapy, and radiation therapy.
- To discuss the future of lung cancer treatment, including molecular staging.
Main Methods:
- Review of advancements in surgical techniques (e.g., video-assisted thoracic surgery).
- Analysis of new imaging modalities (e.g., spiral CT, PET/CT, endobronchial ultrasound).
- Examination of complementary therapies (e.g., targeted chemotherapy, advanced radiation, Cyberknife, radiofrequency ablation).
Main Results:
- Minimally invasive surgery, like VATS lobectomy, is increasingly common.
- Sophisticated imaging has improved lung cancer screening, diagnosis, and staging.
- Lung cancer treatment is now a multimodality approach, with surgery as a key component.
- Adjuvant therapies enhance the effectiveness of surgical resection.
Conclusions:
- Surgical excision remains the most effective local treatment for early-stage lung cancer.
- Lung cancer management has transitioned to a complex multimodality strategy.
- Future advancements, including molecular profiling, will further refine treatment personalization and predict chemosensitivity.